Arax Advisory Partners’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding MBOT
Arax Advisory Partners's MBOT Position: Q2 2026 in Review
Arax Advisory Partners increased its Microbot Medical (MBOT) stake by 0.09% in Q2 2026, buying an estimated $2 and bringing the position to 1,108 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4800.
Arax Advisory Partners first reported a position in MBOT in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.67K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.
- Arax Advisory Partners held 1,108 shares of Microbot Medical worth $2.16K as of Q2 2026.
- Arax Advisory Partners bought 1 Microbot Medical share in Q2 2026, an estimated $2.
- Microbot Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4800 holding.
- Arax Advisory Partners first reported a position in Microbot Medical in Q3 2025 and has held it in 4 quarters since.
- Arax Advisory Partners's Microbot Medical position peaked at $2.67K in Q1 2026.
- 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.